CD274 and cancer: Currently, numerous clinical trials testing combinations of established immune checkpoint inhibitors (PD-1 and PD-L1 antibodies) with conventional treatments (chemotherapy, radiation, or targeted therapy) are carried out and are likely to result in improved treatment modalities for many different types of cancer (180).